Corless CL, Barnett CM, Heinrich MC, et al: Gastrointestinal stromal tumors: origin and molecular oncology. Nat Rev Cancer 11: 865-878, 2011
Tarn C, Rink L, Merkel E, et al: Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci 105 (24): 8387-8392, 2008
Bauer S, Yu LK, Demetri GD, et al: Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor. Cancer Res 66(18): 9153-9161, 2006
Wilhelm SM, Dumas J, Adnane L, et al: Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int J Cancer 129(1): 245-255, 2011
Demetri GD, Reichardt P, Kang YK, et al: Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381: 295-302, 2013